Navigating the Equity Landscape of 2025: Insights and Future Opportunities
“2025 has been a year of two halves for equity investors,” observes Derren Nathan, head of equity research at Hargreaves Lansdown. This year has proven to be a rollercoaster of economic factors, investor sentiment, and market resilience.
A Year Marked by Mixed Performance
Overall, Nathan notes that markets have held up relatively well, showcasing a robust performance despite the various headwinds faced throughout the year. However, as we look toward 2026, global tensions and a mixed economic outlook signal the potential for more volatile markets and sharper share price swings. Investors are reminded that the landscape is ever-evolving, and adaptability is key.
Embracing Uncertainty: The Long-Term Investor’s Advantage
In times of uncertainty, there lies opportunity for long-term investors. “Trying to call every short-term turn rarely works,” Nathan explains. Instead of betting on a singular theme or market, he advocates for a diversified investment strategy. “A better plan is to spread money across regions, sectors, and asset types.” This strategy allows investors to cushion against market volatility while positioning themselves for sustainable growth.
Spotlight on Diversification: Three Shares to Watch
For those looking to diversify and fortify their portfolios, Hargreaves Lansdown has identified three shares to watch as we transition into 2026, each bringing unique opportunities and themes to the table.
Marks & Spencer: A Comeback Story
Marks & Spencer (MKS.L) enters 2026 aiming to recover from a challenging year marred by a cyber-attack that disrupted online sales, particularly in its Fashion, Home & Beauty divisions. Despite these challenges, Nathan emphasizes that the Food division has continued to attract customers. With expectations of returning systems back to normal by spring, there’s cautious optimism surrounding the company’s recovery. “If spending on digital and margins pays off, profits could bounce back,” Nathan states. The insights point to a potential turnaround for a brand that’s been an enduring staple in consumer retail.
Novo Nordisk: Navigating Challenges in Healthcare
Novo Nordisk (NVO), known for its role in diabetes and obesity care, faced a tough year in 2025 due to tight supply, competitive pressures, and pricing dilemmas. However, Nathan underscores that the demand for its products remains substantial. With plans for increased factory capacity, stronger measures against illegal copy drugs, and the recent approval of an oral weight-loss pill, there’s a renewed sense of optimism about its future. As healthcare continues to adapt and innovate, Novo Nordisk stands positioned to capitalize on evolving market needs.
Nvidia: Powering the AI Revolution
Nvidia (NVDA) remains instrumental in the AI sector, dynamically shaping the future of technology and computing. Nathan indicates that while competition is intensifying, and larger buyers are seeking multiple suppliers, Nvidia’s rapid innovation in chip development keeps it at the forefront of big tech spending. With its established foothold and ongoing advancements, Nvidia is likely to continue being a pivotal player in the burgeoning AI landscape, making it a noteworthy investment opportunity.
Final Thoughts
The year 2025 has indeed shaped up to be a complex yet enlightening time for equity investors. As we transition into 2026, the key takeaway remains clear: adaptability, diversification, and a long-term perspective are crucial in navigating the uncertain waters ahead. Whether you’re a seasoned investor or just starting out, embracing these principles can lead to more resilient and growth-oriented investing.
